The Primary
Care Companionfor CNS Disorders

Schizophrenia/Schizoaffective Disorders

Letter to the Editor June 1, 2004

Banned, but Not Forgotten: A Case of Ephedrine-Induced Psychosis

Thomas J. Kim, MD, MPH; H. W. LeBourgeois III, MD

Prim Care Companion J Clin Psychiatry 2004;6(3):136-137

Article Abstract

Banned, but Not Forgotten: A Case of Ephedrine-Induced Psychosis.

About the Authors

Download Free PDF

This PDF is free for all visitors!

Save

Cite

Sponsored

PsychCase360: Choosing the Right Long-Acting Injectable for Patients With Schizophrenia

Explore two real-world schizophrenia cases with Roueen Rafeyan, MD and Melissa Vitale, PMHNP as they discuss challenges with medication adherence, transitioning to long-acting injectables (LAIs), and personalizing treatment strategies to improve patient outcomes.

Vol 27 • 2025 • Number 4

Read the Current Issue

Letter to the Editor

Knowledge of ECT for Catatonia

Original Research

Predictors of Depression Response in a Community ECT Clinic

Original Research

Medical Student Reactions to Interviewing Psychiatric Inpatients

Review Article

Climate Change and Mental Health

Rounds in the General Hospital

Management of Functional Neurological Disorder

Rounds in the General Hospital

PTSD Management in Primary Care

View current Issue

Related Articles

Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?

Letter to the Editor

Does the Onset of Efficacy for Agitation Vary Depending on the Administration Route of Antipsychotics?

March 20, 2024

As choice of administration route is crucial during psychiatric emergencies, the authors stress the need for RCTs comparing onset of efficacy for agitation across different administration routes of the...

Xintong Mu, Hiroyoshi Takeuchi

Asenapine, Aggression, and Affinity

Letter to the Editor

Asenapine, Aggression, and Affinity

September 28, 2022

Dr El-Mallakh comments on a recent study by Citrome et al and discusses his group’s research on antiaggression effects of clozapine.

Rif S. El-Mallakh

A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital Aripiprazole

Letter to the Editor

A Mirror-Image Trial or Smoke and Mirrors? Phase 3b Study on Digital Aripiprazole

August 3, 2022

This letter comments on methodological aspects of a recent study by Cohen et al.

Barbara Mintzes, Alain Braillon, Florian Naudet, et al